Antibody fights pediatric brain tumors in preclinical testing, study finds

(Stanford University Medical Center) Five types of pediatric brain cancer were safely and effectively treated in mice by an antibody that causes immune cells to engulf and eat tumors without hurting healthy brain cells, according to a new study by researchers at the Stanford University School of Medicine.